Tenderwize
Wróć do wyszukiwania

Open House Contract for Peginterferon beta 1a

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2028 · 705 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 20 - Peginterferon beta 1a

56/100

Ocena szansy

Needs reviewHigh complexity
SuppliesOpen
Skąd ta ocena?

Szansa

56 / 100

Złożoność

68 / 100

Czynniki ryzyka

Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...

Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Conclude non-exclusive discount agreements for Peginterferon beta 1a under § 130a Abs. 8 SGB V.
  • Provide pharmaceutical products for nationwide performance in Germany.
Pokaż pełne podsumowanie

This is a German Open House supply arrangement by Techniker Krankenkasse for the active substance Peginterferon beta 1a (CPV 33600000 Pharmaceutical products). It is not an exclusive award procedure: all pharmaceutical undertakings meeting the stated conditions may enter into the contract on uniform terms. The contract term is up to 24 months from 01.08.2026 and ends no later than 31.07.2028, with earlier automatic termination if patent/market exclusivity ends. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. No contract value is stated.

Ryzyka

Offers/contracts cannot be submitted through the e-procurement portal; the notice says this is technically not possible...

Only pharmaceutical undertakings meeting AMG and seat/authorisation conditions may contract.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4 Abs. 18 AMG for the offered medicine(s).
  • Applicant must have its registered seat in the scope of the AMG, another EU Member State, or another EEA state.
  • Applicant must have a valid authorisation for the contract medicine or otherwise be entitled to market it in its own name.

Kryteria udzielenia

Lot 1

No substantive award criteria stated; form-only criterion in an Open House procedure.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House Contract for Peginterferon beta 1a

Open House supply arrangement for Peginterferon beta 1a. The notice indicates nationwide performance in Germany. Contract terms are uniform and non-exclusive; no individual negotiations are conducted. The lot information is taken from structured data and XML notice.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jul 2026 - Jul 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No substantive award criteria stated; form-only criterion in an Open House procedure.

Termin

Deadline Jul 30, 2028

Szczegóły zamówienia

Data publikacji
31 May 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
372206-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3